SCHEMBL6672

SCHEMBL6672

Cc1noc(-c2ccc(Br)cc2)c1C(C=O)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.37
BRD4 O60885 4/20 0.36
BRD2 P25440 4/20 0.36
BRD3 Q15059 4/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NR3C1 P04150 1/20 0.35
NR3C2 P08235 1/20 0.35
LPAR1 Q92633 2/20 0.35
MMP2 P08253 3/20 0.34
MMP1 P03956 2/20 0.34
MMP3 P08254 2/20 0.34
MMP7 P09237 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6836 0.83 ALDH1A1 (0.38) TP53BRD4BRD2BRD3CYP1A2
SCHEMBL18597896 0.78 HPGD (0.39) TP53BRD4BRD2BRD3CYP1A2
SCHEMBL6835 0.78 HPGD (0.39) TP53BRD4BRD2BRD3CYP1A2
SCHEMBL1625 0.77 AR (0.37) TP53BRD4CYP2C9LMNARAB9A
SCHEMBL1933 0.77 EPHX1 (0.34) TP53BRD4LMNARAB9ASMN1; SMN2
SCHEMBL6830 0.76 RAB9A (0.34) TP53BRD4BRD2BRD3CYP1A2
SCHEMBL6496 0.75 TP53 (0.37) TP53BRD4BRD2BRD3CYP2C9
SCHEMBL6561 0.74 LPAR1 (0.34) CYP2C9TDP1RAB9ASMN1; SMN2LPAR1
SCHEMBL2761302 0.73 RAB9A (0.42) CYP2C9LMNARAB9ASMN1; SMN2L3MBTL1
SCHEMBL2836880 0.73 RAB9A (0.42) CYP2C9LMNARAB9ASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed